Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eisai Co. Ltd (ESAIY)

Eisai Co. Ltd (ESAIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 8,854,472
  • Shares Outstanding, K 1,166,597
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta 0.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/01/70
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.0000 +8.86%
on 12/22/25
7.6300 -0.13%
on 01/12/26
+0.4200 (+5.83%)
since 12/12/25
3-Month
6.8500 +11.24%
on 11/11/25
8.1800 -6.85%
on 11/26/25
+0.2400 (+3.25%)
since 10/10/25
52-Week
5.9400 +28.28%
on 04/09/25
9.2200 -17.35%
on 09/08/25
+0.9400 (+14.07%)
since 01/10/25

Most Recent Stories

More News
Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi

Biogen's shares decline after approval of Alzheimer's treatment Leqembi, which modestly slows cognitive decline. Analysts see hurdles to the rollout.

ESAIY : 7.6200 (+0.40%)
XLV : 157.38 (+0.04%)
ESALY : 61.5100 (-2.11%)
LLY : 1,081.00 (+1.64%)
BIIB : 185.63 (-1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Eisai Co. Ltd. engages in the research and development, manufacture, sale and import and export of pharmaceuticals principally in Japan. It offers Dayvigo, for the treatment of insomnia. The company also provides Methycobal for the treatment of peripheral neuropathy; Jyseleca, a janus kinase inhibitor;...

See More

Key Turning Points

3rd Resistance Point 7.8767
2nd Resistance Point 7.7533
1st Resistance Point 7.6867
Last Price 7.6200
1st Support Level 7.4967
2nd Support Level 7.3733
3rd Support Level 7.3067

See More

52-Week High 9.2200
Fibonacci 61.8% 7.9670
Last Price 7.6200
Fibonacci 50% 7.5800
Fibonacci 38.2% 7.1930
52-Week Low 5.9400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar